Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome

被引:141
作者
Bednarska, Olga [1 ,2 ]
Walter, Susanna A. [1 ,2 ]
Casado-Bedmar, Maite [1 ]
Strom, Magnus [1 ,2 ]
Salvo-Romero, Eloisa [3 ]
Vicario, Maria [3 ]
Mayer, Emeran A. [4 ]
Keita, Asa V. [1 ]
机构
[1] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden
[2] Linkoping Univ, Dept Gastroenterol, Linkoping, Sweden
[3] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Vall dHebron Inst Recerca, Digest Dis Res Unit,Lab Translat Mucosal Immunol, Barcelona, Spain
[4] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, G Oppenheimer Ctr Neurobiol Stress & Resilience, Los Angeles, CA 90095 USA
关键词
Intestinal Permeability; Bacteria; Ketotifen; Inflammation; FOLLICLE-ASSOCIATED EPITHELIUM; VISCERAL HYPERSENSITIVITY; ESCHERICHIA-COLI; SALMONELLA GASTROENTERITIS; IMMUNE ACTIVATION; BARRIER FUNCTION; PREDOMINANT IBS; ABDOMINAL-PAIN; GUT MICROBIOTA; ION-TRANSPORT;
D O I
10.1053/j.gastro.2017.06.051
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is associated with intestinal dysbiosis and symptoms of IBS develop following gastroenteritis. We aimed to study the passage of live bacteria through the colonic epithelium, and determine the role of mast cells (MCs) and vasoactive intestinal polypeptide (VIP) in barrier regulation in IBS and healthy individuals. METHODS: Colon biopsies from 32 women with IBS and 15 age-matched healthy women (controls) were mounted in Ussing chambers; we measured numbers of fluorescently labeled Escherichia coli HS and Salmonella typhimurium that passed through from the mucosal side to the serosal side of the tissue. Some biopsies were exposed to agents that block the VIP receptors (VPAC1 and VPAC2) or MCs. Levels of VIP and tryptase were measured in plasma and biopsy lysates. Number of MCs and MCs that express VIP or VIP receptors were quantified by immunofluorescence. Biopsies from an additional 5 patients with IBS and 4 controls were mounted in chambers and Salmonella were added; we studied passage routes through the epithelium by transmission electron microscopy and expression of tight junctions by confocal microscopy. RESULTS: In colon biopsies from patients with IBS, larger numbers of E coli HS and S typhimurium passed through the epithelium than in biopsies from controls (P <.0005). In transmission electron microscopy analyses, bacteria were found to cross the epithelium via only the transcellular route. Bacterial passage was reduced in biopsies from patients with IBS and controls after addition of antibodies against VPACs or ketotifen, which inhibits MCs. Plasma samples from patients with IBS had higher levels of VIP than plasma samples from controls. Biopsies from patients with IBS had higher levels of tryptase, larger numbers of MCs, and a higher percentage of MCs that express VPAC1 than biopsies from controls. In biopsies from patients with IBS, addition of Salmonella significantly reduced levels of occludin; subsequent addition of ketotifen significantly reversed this effect. CONCLUSIONS: We found that colonic epithelium tissues from patients with IBS have increased translocation of commensal and pathogenic live bacteria compared with controls. The mechanisms of increased translocation include MCs and VIP.
引用
收藏
页码:948 / +
页数:16
相关论文
共 65 条
[1]
Colonic Mucosal Immune Activity in Irritable Bowel Syndrome: Comparison with Healthy Controls and Patients with Ulcerative Colitis [J].
Ahn, Ji Yong ;
Lee, Kyung Hun ;
Choi, Chang Hwan ;
Kim, Ju Wan ;
Lee, Hyun Woong ;
Kim, Jeong Wook ;
Kim, Mi Kyung ;
Kwon, Gui Young ;
Han, Seungbong ;
Kim, Seong-Eun ;
Kim, Sung Min ;
Chang, Sae Kyung .
DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (05) :1001-1011
[2]
Expression of inducible nitric oxide synthase in mast cells contributes to the regulation of inflammatory cytokines in irritable bowel syndrome with diarrhea [J].
An, S. ;
Zong, G. ;
Wang, Z. ;
Shi, J. ;
Du, H. ;
Hu, J. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 (07) :1083-1093
[3]
Luminal Cysteine-Proteases Degrade Colonic Tight Junction Structure and Are Responsible for Abdominal Pain in Constipation-Predominant IBS [J].
Annahazi, Anita ;
Ferrier, Laurent ;
Bezirard, Valerie ;
Leveque, Mathilde ;
Eutamene, Helene ;
Ait-Belgnaoui, Afifa ;
Coeffier, Moise ;
Ducrotte, Philippe ;
Roka, Richard ;
Inczefi, Orsolya ;
Gecse, Krisztina ;
Rosztoczy, Andras ;
Molnar, Tamas ;
Ringel-Kulka, Tamar ;
Ringel, Yehuda ;
Piche, Thierry ;
Theodorou, Vassilia ;
Wittmann, Tibor ;
Bueno, Lionel .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (08) :1322-1331
[4]
VIP, SEROTONIN, AND EPINEPHRINE MODULATE THE ION SELECTIVITY OF TIGHT JUNCTIONS OF GOLDFISH INTESTINE [J].
BAKKER, R ;
DEKKER, K ;
DEJONGE, HR ;
GROOT, JA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (02) :R362-R368
[5]
Barbara G, 2016, GASTROENTEROLOGY
[6]
Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation [J].
Berkes, J ;
Viswanathan, VK ;
Savkovic, SD ;
Hecht, G .
GUT, 2003, 52 (03) :439-451
[7]
The Expression and the Cellular Distribution of the Tight Junction Proteins Are Altered in Irritable Bowel Syndrome Patients With Differences According to the Disease Subtype [J].
Bertiaux-Vandaele, Nathalie ;
Youmba, Stephanie Beutheu ;
Belmonte, Liliana ;
Lecleire, Stephane ;
Antonietti, Michel ;
Gourcerol, Guillaume ;
Leroi, Anne-Marie ;
Dechelotte, Pierre ;
Menard, Jean-Francois ;
Ducrotte, Philippe ;
Coeffier, Moise .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (12) :2165-2173
[8]
Mucosal Immune Cell Numbers and Visceral Sensitivity in Patients With Irritable Bowel Syndrome: Is There Any Relationship [J].
Braak, Breg ;
Klooker, Tamira K. ;
Wouters, Mira M. ;
Welting, Olaf ;
van der Loos, Chris M. ;
Stanisor, Oana I. ;
van Diest, Sophie ;
van den Wijngaard, Rene M. ;
Boeckxstaens, Guy E. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (05) :715-726
[9]
Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD [J].
Casen, C. ;
Vebo, H. C. ;
Sekelja, M. ;
Hegge, F. T. ;
Karlsson, M. K. ;
Ciemniejewska, E. ;
Dzankovic, S. ;
Froyland, C. ;
Nestestog, R. ;
Engstrand, L. ;
Munkholm, P. ;
Nielsen, O. H. ;
Rogler, G. ;
Simren, M. ;
Ohman, L. ;
Vatn, M. H. ;
Rudi, K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (01) :71-83
[10]
CHAUDHARY NA, 1962, Q J MED, V31, P307